Phoenix, AZ (PRWEB) July 24, 2014
Colleen’s Dream Foundation, in partnership with Fidelity National Title Agency, has donated $10,000 to Johns Hopkins Medicine to fund ovarian cancer research, according to Colleen’s Dream Foundation President Billy Cundiff.
According to Cundiff, this is the second year in a row Colleen's Dream Foundation has supported ovarian cancer research at Johns Hopkins Medicine.
“One of the main goals of Colleen's Dream Foundation is to work with promising young investigators at some of the top research hospitals and universities that are researching ovarian cancer,” says Cundiff. "So it only makes sense that we are once again supporting ovarian cancer research being conducted at Johns Hopkins.”
Cundiff says this year's grant to Johns Hopkins will go to Dr. Hiroyasu Kashima.
According to Dr. Robert Kurman, Director of the Division of Gynecologic Pathology at Johns Hopkins Medicine, Dr. Kashima’s research currently focuses on the prevention of ovarian cancer.
“Prevention is probably the most effective way of reducing morbidity and mortality from ovarian cancer,” says Kurman. “Dr. Kashima’s research, which focuses on re-purposing a drug that has been used for many years for use in preventing ovarian cancer, would be an important breakthrough.”
Kurman adds the grant from Colleen’s Dream Foundation will both support Dr. Kashima’s research and help to launch him as an independent ovarian cancer investigator.
“In his future work, Dr. Kashima will study the molecular mechanisms underlying how statins prevent the development of ovarian cancer,” says Kurman. “These studies will provide the biological basis for the development of clinical trials to determine whether statins can indeed prevent ovarian cancer in high-risk women.”
Cundiff, who is the kicker for the Cleveland Browns, says the $10,000 grant supporting Dr. Kashima's ov
Copyright©2014 Vocus, Inc.
All rights reserved